Article
Quisinostat is a brain-penetrant radiosensitizer in glioblastoma
2022-11-10
Abstract excerpt
<h4>ABSTRACT</h4> In recent years, histone deacetylase inhibitors (HDACi) have garnered considerable interest for the treatment of adult and pediatric malignant brain tumors. However, owing to their broad-spectrum nature and inability to effectively penetrate the blood-brain barrier, HDACi have failed to provide significant clinical benefit to glioblastoma (GBM) patients to date. Moreover, global inhibition of HD...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 038a7e05-8def-579e-a0f3-86ed6f3acd0d
- DOI
- 10.1101/2022.11.09.515859
